Company / Inventory
Phathom Pharmaceuticals, Inc. Inventory History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$5.5M
FY2025
5-year range
$0 / $5.5M
FY2022-FY2025
Trend
+72.0%
vs FY2024
Sector context
#94 of 105
Health Care
What the data says
Among 105 Health Care companies, Phathom Pharmaceuticals, Inc. is in the bottom 10% for inventory. Inventory has increased for 3 consecutive years, from $0 in FY2022 to $6M in FY2025.
Based on SEC 10-K filings.
$6M in FY2025.
Improved from $1M to $6M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 10% in Health CareTop 90% of 105This company $5.5M Sector average $885.3M
▼
-99.4% below sector average
Key checks
Key Insights
- In FY2025, inventory increased 72.0% year-over-year.
- Ranks #94 out of 105 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -6.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.5M | +72.0% |
| FY2024 | $3.2M | +165.6% |
| FY2023 | $1.2M | - |
| FY2022 | $0 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026